Provided by Tiger Trade Technology Pte. Ltd.

Oric Pharmaceuticals Inc.

12.21
-0.3150-2.52%
Post-market: 12.210.00000.00%19:30 EDT
Volume:1.23M
Turnover:15.20M
Market Cap:1.26B
PE:-9.03
High:12.93
Open:12.72
Low:12.17
Close:12.52
52wk High:14.93
52wk Low:7.23
Shares:103.52M
Float Shares:88.69M
Volume Ratio:0.71
T/O Rate:1.39%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3513
EPS(LYR):-1.4747
ROE:-39.80%
ROA:-25.97%
PB:3.31
PE(LYR):-8.28

Loading ...

Oric Pharma Director Richard A. Heyman Disposes of Common Shares Worth $86,518.47

Reuters
·
2 hours ago

Oric Pharma Grants 161,550 Inducement Stock Options to New Hires Under 2022 Plan

Reuters
·
3 hours ago

Oric Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
3 hours ago

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
3 hours ago

Oric Pharma CFO Dominic Piscitelli Disposes of 13,400 Common Shares Worth $181,257.78

Reuters
·
Sep 30

BTIG Initiates ORIC Pharmaceuticals at Buy With $26 Price Target

MT Newswires Live
·
Sep 23

Oric Pharma Grants 39,200 Stock Options, 6,400 RSUs to New Employees Under Inducement Plan

Reuters
·
Sep 05

Oric Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Sep 05

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Sep 05

Himalayas-1: Bayer and ORIC Double Down on Prostate Cancer With New Phase 3 Combo Trial

TIPRANKS
·
Sep 04

ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences

GlobeNewswire
·
Sep 03

Oric Pharma CFO Dominic Piscitelli Disposes of 77,000 Common Shares Worth $1.05 Million

Reuters
·
Aug 29

Pharscin Pharmaceutical Receives Clinical Trial Approval for Glaucoma Eye Drop Candidate

Stock News
·
Aug 13

Oric Pharmaceuticals is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Aug 10

Analysts Offer Insights on Healthcare Companies: Oric Pharmaceuticals (ORIC), Janux Therapeutics Inc (JANX) and Entrada Therapeutics Inc (TRDA)

TIPRANKS
·
Aug 10

Oric Pharma Grants 125,400 Stock Options, 20,550 RSUs to Five New Employees

Reuters
·
Aug 08

Oric Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Aug 08

ORIC Pharmaceuticals Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Aug 08

Evercore ISI Keeps Their Buy Rating on Oric Pharmaceuticals (ORIC)

TIPRANKS
·
Aug 04

Analysts Offer Insights on Healthcare Companies: Oric Pharmaceuticals (ORIC), ClearPoint Neuro (CLPT) and Keros Therapeutics (KROS)

TIPRANKS
·
Aug 04